HungaroTrial CRO has been selected by a US based Sponsor for the full service coverage of a Phase I. First in Human (FIH) vaccination clinical trial with 84 subjects. HT Medical Team has been involved into the protocol review and early project set up activities. HungaroTrial will provide overview and coordinates 6 central laboratories for this GMO study.
Share this
